Delays in TB treatment among people with pulmonary TB in East Africa: findings from a prospective cohort study
Clicks: 1
ID: 320408
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #198 of 208 articles by views in Open forum infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 208 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Background Although timely tuberculosis (TB) diagnosis and treatment are essential to TB elimination, care delays remain a challenge. Understanding factors associated with delayed TB diagnosis and treatment may inform interventions. Methods The TB Sentinel Research Network of the International epidemiology Databases to Evaluate AIDS is a prospective study of people aged ≥15 with pulmonary TB. At sites in Eldoret, Kenya, and Mbarara, Uganda, questionnaires ascertained timing of recalled TB symptom onset; number/setting of healthcare visits prior to TB diagnosis; symptoms; demographics; food insecurity; and TB- and HIV-related stigma. Robust negative binomial regression was used to examine factors associated with longer overall duration from TB symptom onset to documented treatment initiation. Results Among 264 participants—median age 33 years (IQR 25-43), 67% male, 31% people living with HIV (PLHIV), 51% urban residents—median duration from TB symptom onset to treatment initiation was 65.5 days (IQR 33-131). Longer time to TB treatment was associated with female sex, adjusted incidence rate ratio (aIRR) 1.27, 95% CI (1.00-1.61); previous care-seeking at a pharmacy, aIRR 1.53 (1.22-1.92); and dyspnea, aIRR 1.43 (1.09-1.86), or fatigue, 1.63 (1.11-2.37) at initiation. Shorter duration to TB treatment was associated with HIV-positive status, aIRR 0.50 (0.39-0.64). Among PLHIV, shorter duration to TB treatment was associated with CD4 cell count <200 cells/mm3, aIRR 0.63 (0.43-0.93). Conclusions Interventions are needed to increase community-level TB diagnostic access, including at pharmacies and lower levels of care. Decentralized TB testing strategies and tailored interventions for groups with lower care access should be pursued.
| Reference Key |
openalex_W7167937175
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Kirsten Prabhudas-Strycker, Lameck Diero, Winnie Muyindike, Helen Byakwaga, Sylvia Kitur, Joseph Mining’wo, Bob Ssekyanzi, Alexis Byaruhanga, Harold Kooreman, Felix M. Pabon‐Rodriguez, Hong-Ha M Truong, Jayne Lewis-Kulzer, Edwin Onyango Ochomo, Francesca Odhiambo, Suzanne Goodrich, Aggrey Semeere, Neelima Navuluri, K. Wools-Kaloustian, Leslie A. Enane |
| Journal | Open forum infectious diseases |
| Year | 2026 |
| DOI |
10.1093/ofid/ofag392
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.